The RNA therapeutics industry has grown at an exponential rate in recent years highlighted by the recent launch of messenger RNA (mRNA) vaccines to prevent Covid-19. This year's conference will consider how the industry has adapted to these developments and discuss future mRNA therapeutics. The 2022 agenda will explore innovations in targeted RNA delivery, opportunities for RNAi and the landscape for antisense oligonucleotides. Experts from pharma and biotech companies will explore future therapeutic applications of RNA with case studies on the treatment of cardiovascular and neurological diseases, and oncology.
